Cite
Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice
MLA
Haoyang Wang, et al. “Novel FABP3 Ligand, HY-11-9, Ameliorates Neuropathological Deficits in MPTP-Induced Parkinsonism in Mice.” Journal of Pharmacological Sciences, vol. 152, no. 1, May 2023, pp. 30–38. EBSCOhost, https://doi.org/10.1016/j.jphs.2023.02.008.
APA
Haoyang Wang, Kohji Fukunaga, An Cheng, Yifei Wang, Nariko Arimura, Hiroshi Yoshino, Takuya Sasaki, & Ichiro Kawahata. (2023). Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice. Journal of Pharmacological Sciences, 152(1), 30–38. https://doi.org/10.1016/j.jphs.2023.02.008
Chicago
Haoyang Wang, Kohji Fukunaga, An Cheng, Yifei Wang, Nariko Arimura, Hiroshi Yoshino, Takuya Sasaki, and Ichiro Kawahata. 2023. “Novel FABP3 Ligand, HY-11-9, Ameliorates Neuropathological Deficits in MPTP-Induced Parkinsonism in Mice.” Journal of Pharmacological Sciences 152 (1): 30–38. doi:10.1016/j.jphs.2023.02.008.